Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma - Concepedia

Concepedia

Publication | Open Access

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

DOI Full Paper Access

14

Citations

17

References

2013

Year

Neil G. Snowise, Diane Clements, Shuyen Ho, Richard Follows

Current Medical Research and Opinion

Abstract

Clinicaltrials.gov identifiers: NCT01156792 and NCT01248975.

References

	Year	Citations

Page 1